Viabilidade in vitro de células espermáticas ovinas submetidas a diferentes diluentes e a refrigeração / In vitro viability of ovine sperm cells submitted to different diluents and refrigeration

Avaliou-se a viabilidade in vitro de células espermáticas após a adição de três diluentes comerciais, que foram comparados com o diluente tradicional Tris-gema, utilizados no processo de refrigeração do sêmen ovino, em até 48h de armazenamento. Foram utilizados nove ejaculados diários, obtidos de três reprodutores Dorper, com vagina artificial, em três repetições com intervalo de três dias. O sêmen foi mantido a 30ºC, e foram avaliadas suas características macro e microscópicas. Após formação do pool, repetiram-se as avaliações acrescidas da concentração espermática e da integridade do DNA e do acrossoma. Dividiu-se o pool em cinco tratamento, cada um constituído de uma parte de sêmen para três partes dos respectivos diluentes: Equimix (DI), Laiciphos Green Ovine (DII), FR 4 (DIII), Equimix-Gema- Equimix com gema de ovo (DIV) e Tris-Gema (DV). O material obtido em cada tratamento foi subdividido em quadruplicata, refrigerado e mantido a 4ºC até as avaliações da motilidade individual progressiva (MIP), do vigor e da integridade do DNA e do acrossoma, correspondendo a zero, 12, 24, 36 e 48h. Nas avaliações do sêmen, com o DI ocorreu a maior queda de MIP às 12h em relação aos demais grupos (P<0,05). Às 24h, os tratamentos DII, DIV e DV apresentaram a melhor MIP (P<0,05), que não divergiram (P>0,05) entre si; às 48h, o DII e o DV foram melhores (P<0,05) que os demais. Com relação ao vigor, os tratamentos DII e DV apresentaram valores mais elevados (P<0,05) em relação ao DI e DIII, a partir das 12h, e ao DIV, a partir das 24h (P<0,05). Concluiu-se que o diluente Laiciphos Green Ovine, da mesma forma que o Tris-gema, pode ser utilizado na conservação do sêmen a 4ºC por 48h, enquanto o Equimix, acrescido de 20 por cento de gema de ovo, pode ser seja utilizado no armazenamento do sêmen (4ºC) por até 24h.

The in vitro viability of sperm cells following the addition of three commercial diluents was evaluated and compared with the traditional Tris-yolk diluent for the refrigeration of ovine sperm up to 48h of storage. Nine daily ejaculates were obtained from three Dorper breeders using an artificial vagina; three repetitions were performed in a three-day interval. The semen was kept at 30ºC and macro and microscopic characteristics were evaluated. The samples were pooled and the evaluations were repeated, along with assessments of sperm concentration, DNA integrity, and acrosome integrity. The pool was distributed into five treatments, each with one part of semen to three parts of the following diluents: Equimix (DI), Laiciphos Green Ovine (DII), FR 4 (DIII), Equimix-Yolk-Equimix with egg yolk (DIV), and Tris-Yolk (DV). The material of each treatment was aliquoted in quadruplicate, refrigerated, and maintained at 4ºC until the evaluations of the individual progressive motility (IPM), vigor, DNA integrity, and acrosome integrity, corresponding to 0, 12, 24, 36, and 48h. The highest decrease of IPM occurred with DI (at 12h) in comparison to the other diluent groups (P<0.05). At 24h, DII, DIV and DV had the best IPM (P<0.05) and did not diverge from one another (P>0.05). At 48h, DII and DV had the highest values (P<0.05). Regarding vigor, DII and DV had higher values (P<0.05) than DI and DIII at 12h and higher values than DIV at 24h (P<0.05). From the results, like Tris-Yolk, and Laiciphos Green Ovine can be used for the conservation of semen at 4ºC for 48h, whereas Equimix plus 20 percent egg yolk may be used for the storage of semen at 4ºC for up to 24h.

The use of steroid hormones in superovulation of Nelore donors at different stages of estrous cycle.

The objective of the present study was to evaluate the superovulatory response and ova/embryo recovery from Nelore donors following treatment with a controlled internal drug releasing device and estradiol benzoate (CIDR-B program) at different stages of the estrous cycle. The control group (TI; n=40) received a standard superovulation protocol with females of this group being between days 9 and 12 of the estrous cycle (estrus = day 0). The donors that received a CIDR-B program containing 1.9 g progesterone and an intramuscular injection of estradiol benzoate (2 mg) were at day 0 (TII; n=30), between days 2 and 6 (TIII; n=30), days 7 and 12 (TIV; n=30), days 13 and 16 (TV; n=30) and days 17 and 20 (TVI; n=30) of the estrous cycle. Superovulation was induced with 400 IU of p-FSH, divided into eight decreasing doses (80/80; 60/60; 40/40; 20/20) at intervals of 12h. The donors received PGF2alpha (Cloprostenol) 48 h after beginning the treatment and CIDRs were removed 12h later. Artificial inseminations (AI) were performed 12 and 22 h after the initiation of estrus and embryos were collected 7 days after AI. The mean numbers (+/-S.E.M.) of total ova and embryos, viable (transferable) and degenerated embryos were 14.2+/-11.3, 7.4+/-6.9 and 3.2+/-3.5 (TI), 13.3+/-10.4, 7.1+/-6.2 and 3.3+/-4.3 (TII), 13.5+/-7.0, 8.1+/-6.7 and 2.3+/-3.0 (TIII), 17.4+/-9.9, 9.4+/-6.9 and 4.0+/-4.4 (TIV), 16.9+/-8.8, 9.8+/-8.1 and 2.7+/-2.5 (TV) and 13.0+/-7.8, 7.2+/-6.9 and 2.3+/-2.5 (TVI), with no significant differences (P>/=0.05) among groups. Pregnancy rates of 67.1% (TI; n=86/128), 60.8% (TII; n=59/97), 62.5% (TIII; n=73/115), 64.1% (TIV; n=84/131), 72.3% (TV; n=81/112) and 60.6% (TVI; n=63/104) were obtained with embryos transferred from these collections and did not differ significantly (P>/=0.05) among groups. The results of the present study allow us to conclude that a combination of steroid hormones may be used prior to superovulation in Nelore donors, at any stage of the estrous cycle without affecting the efficiency of embryo transfer programs.

Use of steroid hormone treatments prior to superovulation in Nelore donors.

The objective of this study was to evaluate the effectiveness of synchronization of follicular wave emergence using steroid hormone treatments in Nelore cows. Donors were placed into three groups. Those that were between days 9 and 12 of their cycle (estrus=day 0) formed the TI group (n=60), whilst those that were in any other stages of their estrus cycle constituted groups TII (n=60) and TIII (n=60). TI donors were submitted to a standard protocol of superovulation, however, TII and TIII donors were treated with the Syncro-Mate-B (SMB) or Controlled Internal Drug Releasing Device (CIDR-B) programs, respectively. Superovulation was induced with p-FSH, divided into eight decreasing doses at intervals of 12h. The donors received cloprostenol 48h after the beginning of the treatment and progestagens were removed 12h later. Artificial inseminations (AI) were done at 12 and 22h after the initiation of estrus and the embryo collections were done 7 days after AI. In the donors which displayed behavioral estrus, mean (+/-S.E.M.) total ova and viable (transferable) embryos were 15.8+/-1.4 and 8.3+/-1.0 (TI, n=56); 15.6+/-1.3 and 8.9+/-1.0 (TII, n=56); 17.3+/-1.0 and 9.9+/-0.9 (TIII, n=57), respectively, with no significant difference (P > or =0.05) among groups. In those animals that did not displayed behavioral estrus, the mean values of total ova and viable embryos were 3.5+/-1.6 and 0.7+/-0.5 (TI, n=4); 11.5+/-3.9 and 9.0+/-4.4 (TII, n=4); 8.7+/-5.0 and 5.0+/-2.9 (TIII, n=3), respectively, with no significant differences (P > or =0.05) among groups. Pregnancy rates of 62.2% (TI, n=235); 66.4% (TII, n=284) and 65.1% (TIII, n=244) were obtained with embryos transferred from these collections and did not differ significantly (P > or =0.05) among groups. It was concluded that the synchronization of the emergence of follicular waves in Nelore donors is usable and does not harm the efficiency of embryo transfer programs. In addition, in contrast to the standard superovulation protocol, this method permits the use of a large number of donors in a short time period, at any stage of the estrus cycle, minimizing the costs of embryo transfer.